INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,756,559 | -22.5% | 561,561 | 0.0% | 9.73% | -16.2% |
| Q2 2023 | $22,900,458 | +9.4% | 561,561 | 0.0% | 11.62% | +10.2% |
| Q1 2023 | $20,929,378 | +4.7% | 561,561 | -2.0% | 10.54% | +82.1% |
| Q4 2022 | $19,990,226 | -38.9% | 572,950 | -2.0% | 5.79% | -29.4% |
| Q3 2022 | $32,708,000 | +8.1% | 584,483 | 0.0% | 8.21% | +29.6% |
| Q2 2022 | $30,253,000 | -57.8% | 584,483 | -40.7% | 6.33% | +19.8% |
| Q1 2022 | $71,665,000 | -38.8% | 986,173 | -0.5% | 5.28% | +22.7% |
| Q4 2021 | $117,147,000 | -5.3% | 990,752 | +7.4% | 4.31% | +18.7% |
| Q3 2021 | $123,741,000 | -17.8% | 922,411 | -0.8% | 3.63% | -10.9% |
| Q2 2021 | $150,523,000 | +1180.3% | 929,669 | +534.6% | 4.08% | +958.7% |
| Q1 2021 | $11,757,000 | – | 146,490 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |